4. Development of Immunonconjugates for in Vivo Delivery: Cancer Diagnosis, Imaging, and Therapy

  1. Yashwant Pathak2 and
  2. Simon Benita3
  1. Arutselvan Natarajan

Published Online: 23 APR 2012

DOI: 10.1002/9781118229019.ch4

Antibody-Mediated Drug Delivery Systems: Concepts, Technology, and Applications

Antibody-Mediated Drug Delivery Systems: Concepts, Technology, and Applications

How to Cite

Natarajan, A. (2012) Development of Immunonconjugates for in Vivo Delivery: Cancer Diagnosis, Imaging, and Therapy, in Antibody-Mediated Drug Delivery Systems: Concepts, Technology, and Applications (eds Y. Pathak and S. Benita), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9781118229019.ch4

Editor Information

  1. 2

    Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, Florida, USA

  2. 3

    The Institute for Drug Research of the School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel

Author Information

  1. Molecular Imaging Program at Stanford, Department of Radiology, School of Medicine, Stanford University, Stanford, California, USA

Publication History

  1. Published Online: 23 APR 2012
  2. Published Print: 11 MAY 2012

ISBN Information

Print ISBN: 9780470612811

Online ISBN: 9781118229019

SEARCH

Keywords:

  • immunonconjugates for in vivo delivery, in cancer diagnosis;
  • immunoconjugates, the art of conjugation, linker chemistry;
  • immunoconjugates in cancer, and mAbs for specific targets;
  • immunoconjugates for imaging, optimal therapy in cancer;
  • mAb-based therapeutics, ADCs, ATCs using mAbs

Summary

This chapter contains sections titled:

  • Introduction

  • Immunoconjugates

  • Immunoconjugates in Cancer Therapy

  • Immunoconjugates for Imaging

  • Immunoconjugates in Diagnostic Applications

  • Immunoconjugates' Promising Future and Challenges

  • Summary

  • References